30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Universal Health Services, Inc. trades at 8.9x earnings, 27% below its 5-year average of 12.3x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.7x, the stock trades at a discount of 62%. On a free-cash-flow basis, the stock trades at 0.0x P/FCF, 100% below the 5-year average of 94.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3M | $14.1B | $12.2B | $10.7B | $10.4B | $10.9B | $11.8B | $12.8B | $10.9B | $10.9B | $10.5B |
| Enterprise Value | $5.0B | $19.1B | $17.0B | $15.9B | $15.6B | $15.3B | $14.7B | $17.0B | $14.8B | $14.9B | $14.6B |
| P/E Ratio → | 8.92 | 9.44 | 10.67 | 14.90 | 15.41 | 10.97 | 12.51 | 15.71 | 14.01 | 14.51 | 14.90 |
| P/S Ratio | 0.00 | 0.81 | 0.77 | 0.75 | 0.78 | 0.86 | 1.02 | 1.12 | 1.01 | 1.05 | 1.07 |
| P/B Ratio | 1.79 | 1.90 | 1.80 | 1.72 | 1.74 | 1.75 | 1.84 | 2.29 | 2.00 | 2.16 | 2.27 |
| P/FCF | 0.00 | 16.55 | 10.84 | 20.37 | 39.70 | 387.06 | 7.24 | 16.48 | 20.65 | 19.05 | 78.54 |
| P/OCF | 0.00 | 7.54 | 5.89 | 8.43 | 10.44 | 12.28 | 4.99 | 8.88 | 8.15 | 9.23 | 8.12 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Universal Health Services, Inc.'s enterprise value stands at 1.9x EBITDA, 77% below its 5-year average of 8.4x. The Healthcare sector median is 13.8x, placing the stock at a 86% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.10 | 1.07 | 1.12 | 1.16 | 1.21 | 1.28 | 1.50 | 1.38 | 1.43 | 1.49 |
| EV / EBITDA | 1.93 | 7.30 | 7.51 | 9.14 | 9.82 | 8.07 | 7.89 | 9.98 | 9.10 | 8.61 | 8.58 |
| EV / EBIT | 2.52 | — | 10.12 | 13.95 | 15.68 | 11.11 | 10.85 | 13.85 | 12.54 | 11.73 | 11.52 |
| EV / FCF | — | 22.47 | 15.14 | 30.37 | 59.42 | 545.57 | 9.06 | 21.97 | 28.00 | 25.97 | 109.32 |
Margins and return-on-capital ratios measuring operating efficiency
Universal Health Services, Inc. earns an operating margin of 11.5%. Operating margins have expanded from 8.2% to 11.5% over the past 3 years, signaling improving operational efficiency. ROE of 21.0% indicates solid capital efficiency. ROIC of 12.4% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 90.0% | 89.3% | 89.0% | 88.7% | 88.9% | 89.0% | 89.2% | 89.4% | 89.4% |
| Operating Margin | 11.5% | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% |
| Net Profit Margin | 8.6% | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.0% | 21.0% | 17.6% | 11.8% | 11.1% | 15.7% | 15.7% | 14.7% | 14.8% | 15.6% | 15.3% |
| ROA | 9.9% | 9.9% | 8.0% | 5.2% | 5.1% | 7.5% | 7.5% | 7.1% | 7.1% | 7.1% | 7.0% |
| ROIC | 12.4% | 12.4% | 10.9% | 7.8% | 6.9% | 10.2% | 10.6% | 9.5% | 9.6% | 10.8% | 11.6% |
| ROCE | 16.2% | 16.2% | 13.9% | 10.0% | 8.8% | 12.3% | 12.9% | 12.2% | 12.5% | 14.3% | 14.6% |
Solvency and debt-coverage ratios — lower is generally safer
Universal Health Services, Inc. carries a Debt/EBITDA ratio of 2.0x, which is manageable (36% below the sector average of 3.1x). Net debt stands at $5.0B ($5.2B total debt minus $138M cash). Interest coverage of 12.8x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.70 | 0.70 | 0.73 | 0.87 | 0.88 | 0.74 | 0.65 | 0.77 | 0.73 | 0.80 | 0.90 |
| Debt / EBITDA | 1.98 | 1.98 | 2.19 | 3.08 | 3.32 | 2.40 | 2.24 | 2.53 | 2.46 | 2.34 | 2.44 |
| Net Debt / Equity | — | 0.68 | 0.71 | 0.85 | 0.87 | 0.72 | 0.46 | 0.76 | 0.71 | 0.78 | 0.89 |
| Net Debt / EBITDA | 1.92 | 1.92 | 2.13 | 3.01 | 3.26 | 2.34 | 1.59 | 2.49 | 2.39 | 2.29 | 2.42 |
| Debt / FCF | — | 5.92 | 4.30 | 10.00 | 19.73 | 158.51 | 1.83 | 5.48 | 7.36 | 6.92 | 30.79 |
| Interest Coverage | 12.78 | 12.78 | 8.97 | 5.67 | 7.89 | 15.99 | 12.45 | 7.47 | 7.58 | 8.96 | 10.98 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.05x means Universal Health Services, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.40x to 1.05x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | 1.05 | 1.27 | 1.40 | 1.33 | 1.14 | 1.32 | 1.23 | 1.34 | 0.97 | 1.28 |
| Quick Ratio | 1.05 | 1.05 | 1.17 | 1.29 | 1.21 | 1.04 | 1.25 | 1.12 | 1.24 | 0.90 | 1.18 |
| Cash Ratio | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 | 0.06 | 0.49 | 0.04 | 0.07 | 0.04 | 0.03 |
| Asset Turnover | — | 1.12 | 1.09 | 1.02 | 0.99 | 0.97 | 0.86 | 0.98 | 0.96 | 0.97 | 0.95 |
| Inventory Turnover | — | — | 7.19 | 7.06 | 6.75 | 6.90 | 6.76 | 7.83 | 7.89 | 8.12 | 8.23 |
| Days Sales Outstanding | — | 54.70 | 50.22 | 57.20 | 54.96 | 50.43 | 54.60 | 50.07 | 51.16 | 52.63 | 53.80 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Universal Health Services, Inc. returns 100.0% to shareholders annually — split between a 0.4% dividend yield and 100.0% buyback yield. The earnings yield of 11.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.1% | 0.4% | 0.3% | 0.4% | 0.4% |
| Payout Ratio | — | — | 4.7% | 7.7% | 8.7% | 6.6% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 11.2% | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% |
| FCF Yield | 100.0% | 6.0% | 9.2% | 4.9% | 2.5% | 0.3% | 13.8% | 6.1% | 4.8% | 5.2% | 1.3% |
| Buyback Yield | 100.0% | 6.9% | 5.5% | 5.1% | 8.0% | 11.3% | 1.8% | 6.0% | 3.6% | 3.3% | 3.4% |
| Total Shareholder Yield | 100.0% | 7.3% | 5.9% | 5.6% | 8.6% | 11.9% | 1.9% | 6.4% | 4.0% | 3.7% | 3.7% |
| Shares Outstanding | — | $64M | $68M | $70M | $74M | $84M | $86M | $89M | $94M | $96M | $98M |
Compare UHS with 8 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| UHSYou | $3M | 8.9 | 1.9 | 0.0 | — | 11.5% | 21.0% | 12.4% | 2.0 |
| HCA | $118B | 18.7 | 10.8 | 15.4 | 41.5% | 15.8% | — | 19.9% | 3.2 |
| THC | $21B | 15.5 | 7.2 | 8.3 | 41.4% | 16.5% | 16.1% | 13.5% | 3.0 |
| MPW | $3B | -16.5 | 100.9 | 14.1 | — | — | -4.2% | — | 4.6 |
| ACHC | $2B | -1.9 | 8.0 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
| ARDT | $1B | 5.9 | 5.6 | 10.5 | 82.7% | 6.8% | 16.2% | 9.7% | 4.1 |
| UHT | $605M | 34.3 | 20.7 | 12.3 | — | — | 10.6% | — | — |
| CYH | $485M | 0.9 | 0.5 | 2.3 | 56.7% | 11.9% | — | 21.0% | 0.3 |
| AUNA | $161M | 11.0 | 4.4 | 0.9 | 37.2% | 16.1% | 6.5% | 10.0% | 4.1 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how UHS stacks up against sector leader HCA Healthcare, Inc..
Start ComparisonUniversal Health Services, Inc.'s current P/E ratio is 8.9x. The historical average is 16.0x.
Universal Health Services, Inc.'s current EV/EBITDA is 1.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.1x.
Universal Health Services, Inc.'s return on equity (ROE) is 21.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.5%.
Based on historical data, Universal Health Services, Inc. is trading at a P/E of 8.9x. Compare with industry peers and growth rates for a complete picture.
Universal Health Services, Inc.'s current dividend yield is 0.39%.
Universal Health Services, Inc. has 11.5% operating margin. Operating margin between 10-20% is typical for established companies.
Universal Health Services, Inc.'s Debt/EBITDA ratio is 2.0x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.